As part of a QCDR, the US Wound & Podiatry Registries serve many purposes beyond helping medical providers report for MIPS:
Follow the natural history of a disease
Estimate the magnitude of a problem
Document the type of patients served
Estimate complication rates
Understand variations in outcomes
Determine clinical effectiveness of treatments in the real world
Measure and improve clinical quality
The field of Wound Care has a unique need for Registry data because federally funded clinical research is minuscule in relation to the impact of the diseases treated by physicians.
The US Wound Registry is a low-cost, but scientifically valid, way for every practicing physician to advance both science and patient care, while meeting Medicare mandates for data reporting under new healthcare legislation.
We Impact Several Pieces of the Medical Industry:
The Centers for Medicare and Medicaid Services (CMS) transitioned physician payment to the Merit-based Incentive Payment System (MIPS), and private payers are following suit. As of January 2017, your Medicare Part B payments (and probably payment from all the other payers) will be linked in large part to the reporting of clinical Quality Measures using your EHR. Transmitting data to the US Wound & Podiatry Registries is another way to accumulate points for Promoting Interoperability (formerly Meaningful Use) within MIPS.
Unless you’re an IntellicureEHR user, when you join the US Wound & Podiatry Registries, you will send us your Continuity of Care Documents (CCDs). The data in CCDs will be used to provide you with benchmarking reports that will compare your patient and practice data in comparison with national aggregate data. You can look for outliers in your practice patterns or use of technology, and you can understand the risk level of your patients in comparison to the rest of the country. You can use benchmarking reports for Quality Improvement (QI) activities by identifying which practice patterns might be outside of the norm. You can also use these reports to identify the prevalence rate of certain co-morbid diseases like diabetes in your practice. These data can be used to understand the importance of care in prevention of diabetic lower extremity amputations.
Reporting to the US Wound & Podiatry Registries means you will also have access to business intelligence metrics. This is especially important as providers struggle to develop compliance plans in advance of increasing scrutiny from federal recoupment programs.
The US Wound and Podiatry Registries are Qualified Clinical Data Registries (QCDRs). We can use Registry data to determine whether practitioners are following evidence-based guidelines for clinical patient care. You can compare yourself with your peers in both quality and patient outcomes. This is important in an era when quality data will be publicly reported by Medicare on websites like Physician Compare using measures that may not be relevant to your specialty. You can access your confidential benchmarking reports via our secure portal. If you identify practice patterns that are outside the norm, you can create Quality Improvement (QI) goals for your practice. Using data reported through our Registry for QI is an Improvement Activity (IA) in MIPS.
Striving for Health Equity
Chronic diseases are a significant problem in the US. Physicians care for many patients who struggle to cope with the burden of managing chronic diseases like diabetes, in addition to social, language, and economic barriers. CMS has identified areas of disparities between subgroups of Medicare beneficiaries (e.g., racial and ethnic groups) in health outcomes, utilization, and spending. The US Wound & Podiatry Registries can help you understand whether your practice is caring for patients likely to live in an area where disparities exist. Using our Registry to screen for social determinants of health is another Improvement Activity that counts toward your MIPS score.
Registry participation can help patients. Clinical trials usually exclude patients with serious co-morbid diseases and target the least severe problems. As a result, while clinical trials can prove an intervention or device is efficacious under perfect conditions, they can’t prove it is effective in the real world. Because payer coverage policy usually mirrors the criteria of a clinical trial, the patients who most need a treatment or a product are later excluded from receiving it by coverage policy. The data from registries can be used to improve payer coverage policy by providing information about the effectiveness interventions in different real world populations.
The US Wound Registry is listed on the National Institute of Health (NIH) Clinical Trials website.